News

Mylan settles suit over asthma, allergy drug

BY Alaric DeArment

PITTSBURGH — Mylan has settled a patent infringement suit over a drug used to treat respiratory diseases, Mylan said.

The generic drug maker said it resolved a patent litigation suit filed by Shionogi and Cima Labs over prednisolone sodium phosphate orally disintegrating tablets, a generic version of Orapred ODT. Mylan is hoping to market its generic version of the drug in the 10-mg, 15-mg and 30-mg strengths. The drug is used to treat asthma and certain allergic conditions.

Under the settlement, Mylan will be able to launch its product starting in April 2014. The company said it was likely the first company to file a regulatory approval application containing a Paragraph IV certification, a legal assertion that the patent covering the branded drug is invalid, unenforceable or not at risk of being infringed.

Orapred ODT had sales of $33.1 million during the 12-month period ended in June, according to IMS Health.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Shopko names interim CEO

BY Katherine Field Boccaccio

GREEN BAY, Wis. — Shopko announced Wednesday that Mike Bettiga has been named interim CEO to replace Paul Jones, who resigned to pursue another opportunity.

Bettiga is a 35-veteran of the company and most recently served as EVP and COO, a role he has held since April 2009. He began his career with Shopko as a pharmacist in 1977, and has held a number of positions during his tenure, including executive leadership of store, pharmacy and optical operations, retail health merchandising and responsibility for the Shopko Express stores.

"I am grateful for the opportunity to serve as Interim CEO for Shopko, a company that I have been an integral part of for most of my professional career," Bettiga said. "We have ambitious plans for the future, including the continued rollout of the Shopko Hometown concept and I look forward to leading the team on that effort and our other growth initiatives."

In December 2011, Bettiga testified on behalf of the National Association of Chain Drug Stores before the Senate Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights against the ESI-Medco merger.

"We appreciate the many contributions Paul Jones has made to Shopko during the past five years and wish him nothing but the best," said Scott King, senior managing director of Sun Capital Partners, a leading private investment firm whose affiliate owns Shopko. King noted that a national search is under way to select a new leader for the company.

As reported earlier this year, Shopko merged with retailer Pamida, converting all of the latter’s stores to the Shopko Hometown format. Over the summer, the company also had appointed a new SVP and general merchandise manager of home and hardlines and expanded the role of its SVP product development to become responsible for overseeing the retailer’s consumables division.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Petroleum jelly alternative Waxelene expands distribution to Bed Bath & Beyond

BY Antoinette Alexander

SAN FRANCISCO, Calif. — Waxelene, a petroleum jelly alternative, now is being sold in Bed Bath & Beyond retail stores, the company has announced. This brings the total count of retail outlets carrying Waxelene to more than 800 across all 50 U.S. states and Canada.
 
“Retailers and consumers have embraced Waxelene,” Waxelene CEO Todd Cooper said. “It’s an organic product which really appeals to those who are health or eco-conscious. It’s a wonderful baby product so moms have been really supportive. And it’s an amazing, multifunctional beauty and skin care product which has created a tremendous buzz for Waxelene.”
 
Waxelene can be used as a substitute for more expensive and/or less effective beauty products.

“Very soothing with a subtle scent of beeswax and rosemary, Waxelene has become a must in my kit. Unfortunately, every hairdresser and model that I work with will often try to walk away with it. So now I make sure to carry two jars of it with me at all times,” stated Christy Coleman, a professional makeup artist.

Waxelene’s ingredients — vitamin E oil, beeswax, organic rosemary oil, and organic soy oil — are balanced to synergistically care for skin. These all-natural ingredients are combined using a patent pending aeration formula to create a texture that is designed to not clog pores. The product is made in the USA.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?